Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Caplin

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|September 16, 1998
Carcinoid tumourM E Caplin, J R Buscombe, A J Hilson, et al.
Endocrine-Related Cancer|August 14, 2016
A comparison of CellCollector with CellSearch in patients with neuroendocrine tumoursD Mandair, C Vesely, L Ensell, et al.
The European Respiratory Journal|August 1, 1995
Anti-tuberculosis medication and the liver: dangers and recommendations in managementN P Thompson, M E Caplin, M I Hamilton, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.
The American Journal of Gastroenterology|October 15, 1998
Multimodality treatment for gastric carcinoid tumor with liver metastasesM E Caplin, H J Hodgson, A P Dhillon, et al.
Nuclear Medicine Communications|March 16, 2000
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumoursM E Caplin, W Mielcarek, J R Buscombe, et al.
Regulatory Peptides|October 27, 1999
Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopyM E Caplin, P Clarke, S Grimes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2015
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM E Caplin, E Baudin, P Ferolla, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerT Meyer, M E Caplin, D H Palmer, et al.
British Journal of Cancer|June 26, 2008
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patientsT Shah, R Srirajaskanthan, M Bhogal, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|September 16, 1998
Carcinoid tumourM E Caplin, J R Buscombe, A J Hilson, et al.
Endocrine-Related Cancer|August 14, 2016
A comparison of CellCollector with CellSearch in patients with neuroendocrine tumoursD Mandair, C Vesely, L Ensell, et al.
The European Respiratory Journal|August 1, 1995
Anti-tuberculosis medication and the liver: dangers and recommendations in managementN P Thompson, M E Caplin, M I Hamilton, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.
The American Journal of Gastroenterology|October 15, 1998
Multimodality treatment for gastric carcinoid tumor with liver metastasesM E Caplin, H J Hodgson, A P Dhillon, et al.
Nuclear Medicine Communications|March 16, 2000
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumoursM E Caplin, W Mielcarek, J R Buscombe, et al.
Regulatory Peptides|October 27, 1999
Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopyM E Caplin, P Clarke, S Grimes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2015
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM E Caplin, E Baudin, P Ferolla, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerT Meyer, M E Caplin, D H Palmer, et al.
British Journal of Cancer|June 26, 2008
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patientsT Shah, R Srirajaskanthan, M Bhogal, et al.
Pageof 4